Angiosarcoma of the aorta: Report of a case and review of the literature  by Seelig, Matthias H. et al.
732
Primary aortic malignant tumors are extremely
rare. Only 86 cases have been published in the lit-
erature since the first description in 1873.1
Because these cases usually are first seen with
symptoms that are similar to aortoiliac occlusive
disease or acute thromboembolism, preoperative
diagnosis is only occasionally established. The vast
majority of the cases are diagnosed at an autopsy
or at a histologic examination of thromboembolic
material that suggests the presence of an intra-aor-
tic malignant disease. We describe a rare case of an
angiosarcoma of the thoracic aorta, which was
treated with endarterectomy. The related world
literature is reviewed. 
CASE REPORT
A 71-year-old white male was seen with multiple skin
infarcts that involved both feet, the buttocks, and the
lower back. Three months before admission, the patient
first had been seen with a small infarct of the left great toe.
An abdominal ultrasound scan revealed an infrarenal aor-
tic aneurysm with mural thrombus. Renal function was
normal, with a serum creatinine level of 1.0 mg/dL. A
preoperative angiogram showed an infrarenal aortic
aneurysm with widely patent renal arteries. The patient
subsequently had undergone repair of an abdominal aor-
tic aneurysm, which was thought to be the source of
embolism. The only specimen sent at the time of the
aneurysm repair was the intraluminal thrombus, which
had no evidence of malignant disease. After surgery, the
serum creatinine level remained within normal limits.
A physical examination revealed multiple skin infarcts
in both feet. The pulses in both the upper and the lower
extremities were normal. The laboratory test results were
within the normal limits except for a creatinine level of 1.7
mg/dL and an erythrocyte sedimentation rate of 70
mm/h. The work-up consisted of an ultrasound scan of
the abdominal aorta that showed no evidence of an
aneurysm or perigraft abnormalities. A transthoracic
echocardiogram showed normal left ventricular size and
function. No evidence of an intracardiac source of
embolism was seen. A transesophageal echocardiogram
revealed an intraluminal aortic mass at the anterior wall of
the descending thoracic aorta, approximately 35 cm from
the incisors. The patient was treated with heparin and war-
farin with the conviction that the mass represented throm-
bus and that the anticoagulants would stabilize the aortic
mural thrombus and prevent embolization.
Five weeks later, the patient was readmitted with early
satiety, moderate intermittent abdominal pain, generalized
weakness, and malnutrition. On physical examination, the
patient had mild mid-epigastric tenderness. The laborato-
ry test results now showed a marked elevation in the liver
function tests, a prothrombin time of 19.0 seconds, and a
creatinine level of 3.7 mg/dL.
A computed tomography scan of the chest and the
abdomen revealed the intraluminal descending thoracic
aortic mass. In addition, a large avascular lesion in the
right lobe of the liver that was consistent with infarction
and a splenic infarct was detected. A transesophageal
echocardiogram showed a minimal change in the size of
the intra-aortic mass (Fig 1).
A transfemoral biplane aortogram was obtained.
Embolic occlusion of the right hepatic artery and of both
renal arteries beyond the primary branches was identified.
The superior mesenteric and the proximal celiac arteries
were normal.
The intra-aortic lesion was considered an intraluminal
mobile atherothrombotic plaque that resulted in ongoing
peripheral atheroembolization. The patient subsequently
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was taken to the operating room. Cerebrospinal fluid
drainage was used to provide protection against spinal
cord ischemia. Distal aortic perfusion via a BioMedicus
pump (BioMedicus, Minneapolis, Minn) was not believed
to be necessary because the lesion involved the distal tho-
racic aorta and the cross clamp time would be short. A left
posterolateral thoracotomy through the 6th intercostal
space was performed. With intraoperative duplex ultra-
sound scan, the intraluminal mass in the descending aorta
was visualized. Without the use of systemic heparinization,
the descending thoracic aorta below the mass was cross-
clamped first and then followed by the clamping of the
aorta proximal to the lesion to avoid embolization. A lon-
gitudinal aortotomy was made. A large fungating mass was
identified with a relative lack of atherosclerotic changes.
Subsequently, an endarterectomy of the lower descending
thoracic aorta was performed. The distal end point of the
endarterectomy was tacked down with interrupted
polypropylene sutures. The aorta subsequently was closed
because the lesion was primarily thought to be atheroscle-
rotic in nature. The total cross-clamp time was 27 minutes.
Grossly, there were multiple-lobulated fungating lesions
that involved the surface of the specimen with little evi-
dence of atherosclerotic occlusive disease (Fig 2). An intra-
operative frozen section analysis of the endarterectomized
specimen revealed a high-grade, poorly differentiated,
malignant angiosarcoma that involved only the intimal sur-
face of the specimen. All margins were free of tumor, and
therefore, reclamping of the aorta with subsequent resec-
tion and graft replacement was not believed to be neces-
sary. The postoperative course was uneventful. The patient
had no evidence of paraparesis, paraplegia, or renal failure
and was dismissed from the hospital on the 15th postoper-
ative day with a creatinine level of 2.7 mg/dL.
Unfortunately, the patient was readmitted to the hospi-
tal roughly 1 week later with chest pain, “failure-to-thrive”,
and a lack of appetite. The serial creatinine kinase isoenzyme
results were normal, and the serial electrocardiograms
showed no changes. A chest computed tomography scan
showed no evidence for a dissection. On the 14th hospital
day, the patient suddenly had a cardiopulmonary arrest and
could not be resuscitated. Death occurred on the 35th post-
operative day, 6 months after the initial embolic event.
On autopsy examination, no abnormalities from the
Fig 1. Echocardiogram of thoracic aorta reveals a 14 · 15–mm intraluminal mass.
Fig 2. Macroscopic aspect of polypoid tumor of thoracic
aorta after endarterectomy.
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previous surgeries were noted. Tumor emboli were identi-
fied in the hepatic, renal, and splenic arteries. Tumor also
was identified in the areas that corresponded to the skin
infarcts in his feet. No evidence was seen of acute myocar-
dial infarction, pulmonary emboli, or cerebral metastases
to explain his rapid death.
DISCUSSION
Primary malignant disease of the aorta first was
described by W. Brodowski in 1873.1 He described
the tumor as a fibrosarcoma of the aorta. An exten-
sive Medline search revealed that since that time, an
additional 86 cases, including the present case, have
been reported.2-79 Among the 87 cases, there were
59 male patients (67.8%) and 28 female patients
(32.2%; male:female ratio, 2:1). The mean age of the
patients was 60 years (range, 3 months to 82 years).
The following locations of the tumors were report-
ed: abdominal aorta, 39 (44.8%); thoracic aorta, 39
(44.8%); and thoracoabdominal, 9 (10.4%).
The vast majority of these tumors have been of
mesenchymal origin and diagnosed postmortem.
Table I shows the distribution of the tumor types of
all reported cases since 1873. 
Salm22 first described 3 distinctive morphologic
types of primary aortic tumors—intraluminal, intimal,
and adventitial. Polypoid or intraluminal tumors, such
as myxomas, have a focal attachment to the arterial
surface with the vast majority of growth extending
intraluminally as a polypoid mass. The case described
involved an intimal-based tumor. These tumors grow
along the surface of the artery with smaller intralumi-
nal projections. Both the intraluminal and the intimal
tumors are commonly seen with tumor embolization
to the lower extremities and viscera. Occasionally, the
tumor mass itself may cause orificial obstruction of
major branch vessels. Less commonly, the tumor orig-
inates in the media or adventitia with local invasion of
the surrounding structures and transmural arterial
involvement. Wright et al39 proposed a clinicopatho-
logic classification that categorized lesions as intimal
(obstructive and nonobstructive) and mural, thus
mainly combining the polypoid and intimal tumors in
the Salm classification. 
Unfortunately, the prognosis for primary malig-
nant aortic tumors is poor, and metastatic disease
leads to death in most patients. Of the 86 cases
described in the literature, an autopsy was performed
in 59 cases (68.6%). The presence of metastases was
not mentioned in 5 cases (8.5%), and, in 12 cases,
(20.3%) no metastatic disease could be detected.
Metastatic disease was seen at autopsy in 42 of 59
patients (71.2%). Metastases were located primarily
in the bone (28.8%), the kidneys (27.1%), the liver
(23.7%), the adrenal glands (20.3%), and the lungs
(15.3%). The mean survival rate of patients in whom
the diagnosis could be established was 14 months
(median, 7 months; range, 0.25 to 168 months).
Table I. Primary malignant tumors of the aorta. Reported cases in the world literature since 1873 (n = 87).
No. of Thoraco- Male/ Metastases Intimal/
Histology cases Thoracic Abdominal abdominal female (%) Mural* References
Sarcoma 23 7 15 1 18/5 8 (34.8) 22/1 12, 24, 35, 39, 40, 44, 47-49,
58, 67, 71, 76, 79
Malignant fibrous 15 10 4 1 8/7 10 (66.6) 7/8 29, 31, 37, 38, 41-43, 46, 51,
histiocytoma 53, 55, 56, 61, 63, 66, 77
Angiosarcoma 10 4 6 0 8/2 7 (70) 8/2 18, 19, 32, 33, 50, 65, 68, 71, 
78, present case
Leiomyosarcoma 9 3 5 1 4/5 7 (77.8) 2/7 28, 30, 54, 57, 69, 71, 73-75
Fibrosarcoma 9 4 5 0 6/3 6 (66.6) 6/3 1-4, 6, 11, 22, 25, 26
Myxoma 4 3 0 1 2/2 2 (50) 3/1 20, 21, 23, 35, 64
Fibromyxosarcoma 3 1 1 1 2/1 1 (33) 3/0 10, 14, 17
Hemangiopericytoma 2 2 0 0 1/1 1 (50) 0/2 15, 16
Hemangioendothelioma 2 1 1 0 2/0 2 (100) 1/1 34, 72
Malignant endothelioma 2 2 0 0 2/0 2 (100) 2/0 36, 45
Aortic intimal sarcoma 2 0 0 2 2/0 2 (100) 2/0 59, 60, 62
Myxoid chondrosarcoma 1 0 1 0 1/0 1 (100) 1/0 70
Myxosarcoma 1 0 0 1 1/0 0 (0) 1/0 5
Myxomatous 1 0 1 0 1/0 0 (0) 1/0 13
endothelioma
Endotheliosarcoma 1 1 0 0 1/0 0 (0) 1/0 52
Fibromyxoma 1 0 0 1 0/1 1 (100) 1/0 7, 8, 9
Fibroxanthosarcoma 1 1 0 0 0/1 1 (100) 0/1 27
Total 87 39 39 9 59/28 51 (58.6) 61/26
*Tumor location primary in the intima (intimal) or the media and adventitia (mural).
Although the management of this patient may be
controversial, this case depicts many of the pitfalls in
the diagnosis and the treatment of patients with pre-
sumed atheroembolization. The discovery of an
abdominal aortic aneurysm, for example, may
prompt repair without assessment of a potential
proximal source. Atheromatous embolization may
be impossible to differentiate from plaque-related
thromboembolism, cardiac embolism, or, as in this
case, tumor embolism. Furthermore, traditional
diagnostic tests, such as aortography, may exacerbate
atheroembolization or worsen already compromised
renal function.
In our case, the typical presentation of atheroem-
bolization in the presence of an abdominal aortic
aneurysm with mural thrombus resulted in abdomi-
nal aortic aneurysm repair. The persistence of the
symptoms, however, required further evaluation for
a potential source of the emboli. We found that
transesophageal echocardiography was an excellent
tool to clearly delineate the extension of the intra-
aortic mass that was considered atheromatous
mobile debris. Retrograde aortography should be
avoided because of the potential danger of ongoing
atheroembolization.
Higgins et al67 proposed an algorithm for the
diagnosis and the management of patients who are
seen with mesenteric tumor emboli. After the exclu-
sion of a cardiac source with echocardiography, mag-
netic resonance imaging (MRI) of the thorax and
the abdomen was considered the most sensitive
diagnostic tool for the detection of an aortic tumor
because it eliminates the risk of embolization and
provides precise anatomic details that are compara-
ble with that of conventional angiography. In addi-
tion, MRI may provide excellent contrast between
the vessel lumen and the aortic wall and the sur-
rounding tissues. Multiplanar views may be obtained
to diagnose any additional abnormalities, such as
aneurysms or dissection, and qualitative information
regarding intraluminal blood flow may be provided.
Finally, MRI may distinguish intraluminal tumor
from atheromatous material. Transesophageal
echocardiography is another excellent diagnostic test
in identifying thoracic aortic disease and may be
more sensitive in detecting aortic mobile debris.
If intra-arterial tumor emboli are obtained after
emergent peripheral or visceral thromboembolecto-
my, a thorough diagnostic work-up should be per-
formed to determine the location of the primary
tumor. If a localized solitary lesion is identified and
the patient is a “surgical candidate,” then resection of
that lesion should be performed. When malignant
JOURNAL OF VASCULAR SURGERY
Volume 28, Number 4 Seelig et al 735
disease is identified, aortic resection should be per-
formed. Endarterectomy may be performed if intra-
operative histology reveals an intimal-based angiosar-
coma and all deep margins reveal no invasion. If the
patient is not a “surgical candidate” and a large iso-
lated intra-aortic mass is identified, then therapeutic
anticoagulation therapy may dissolve the lesion. We
have reported success in an “inoperable” patient with
distal emboli and a large thoracic aortic mass, which
resolved with anticoagulant therapy. The mass was
presumed to be an intra-aortic thrombus.80 In small-
er series, balloon angioplasty or atherectomy may be
beneficial for solitary lesions in smaller arteries.
On the other hand, if the patient has a diffusely
“shaggy aorta,” treatment is mostly nonsurgical,
supportive, and palliative. Rarely, a patient may have
a shaggy arterial surface localized to a particular por-
tion of the aorta that is amenable to resection or
bypass graft.
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